When Philadelphia celebrates, fans go wild. They climb light poles and just anything else that points straight up. It ...

Tampa Bay Buccaneers quarterback Baker Mayfield has had his doubters. That includes those from the NFL — he was released by ...

Schottenheimer has not been a particularly popular pick among fans and media, and Fox Sports Radio host Colin Cowherd is no ...

The Buffalo Bills lost 32-29 against the Kansas City Chiefs in the AFC Championship, and Colin Cowherd discusses the main reason why: Sean McDermott was outplayed and outcoached.

Colin Cowherd discusses how the Chiefs rise to the occasion in high-pressure situations. JANUARY 27・the herd with colin cowherd・6:00 NFL - Buffalo Bills vs. Kansas City Chiefs - 01/26/2025 ...

Grand Theft Auto 6 is shaping up to be the biggest release of the year, marking the long-awaited return of Rockstar's iconic crime series after 12 years. Set in Vice City, the game has been highly ...

Ill-advised boat purchases have launched countless domestic disputes — but rarely on the scale of the one between Colin Jost and Scarlett Johansson. "If anybody out there would like to start a ...

That's why I'm upgrading VRT to "Buy" today. I may be wrong in my assumptions regarding Vertiv's potential to expand its marginality further. The competition in the space is fierce, so ...

In Wednesday’s edition of The Herd with Colin Cowherd, the Fox personality jokingly ... going because it’s been really fun thus far.” Again, with a $375 million deal, it would take something ...

Jenna put her guest co-host, Scarlett Johansson, up to the test in a segment called "The Great Debate" with her husband, Colin Jost ... Jenna once again sided with her guest co-host, but told ...

He then repeated the gesture before putting his hand on his chest again. It was all done in a matter of seconds, but it was enough for the usual mob to erupt in faux outrage. Pundits insisted that ...

There’s just one minor problem — it’s the stock ticker for the wrong MGX. MGX represents shares of Metagenomi Inc., a biotechnology company focused on leveraging genome editing tools.